Skin cancer can involve melanocytes, leading to melanoma, but there are other non-melanoma skin cancers. These include basal cell carcinoma, squamous cell carcinoma and, less commonly, Merkel cell ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Not all warning signs are visible. Sometimes a spot might itch, tingle, burn, or feel tender when nothing else on your skin ...

Acral lentiginous melanoma is a type of skin cancer. It usually forms in places that do not get much sun. So, it is believed that sun exposure is not a direct cause of it, according to the ...

Some doctors may prescribe medication to specifically address the itching. Skin cancer may cause skin itching without a rash. However, it often presents with some type of skin lesion. People ...

Cena opened up recently about one of the toughest battles he has faced in recent memory – a bout with skin cancer. He revealed in an interview with People late last month that a checkup with the ...

The actress is raising awareness about skin cancer. "Several years ago, I was diagnosed (and thankfully, fully recovered) from melanoma," Michelle Monaghan said. "I LOVE the sun - that’s why I ...

Nearly half of skin cancer patients who underwent surgery still do not use sunscreen, a third do not use protective gear, like hats, and one in six do not avoid the midday sun, a new study has shown.

Older populations are experiencing the most significant increases in skin cancer cases, with invasive melanoma rates rising sharply among those older than 60 years, up to 3% per year in Australia ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.

“We are optimistic that the clinical trial will continue to demonstrate that PH-762 may present a viable non-surgical alternative to existing modes of therapy for skin cancer,” said Robert Bitterman, ...